Status:
COMPLETED
Monitoring Activity And Gait In Children
Lead Sponsor:
Pfizer
Conditions:
Child, Preschool
Child
Eligibility:
All Genders
3-17 years
Brief Summary
COHORT A: To study whether a digital health tool called Actigraph can be used to collect information on gait and physical activity in healthy children aged 3-17. The study will be conducted at the Pfi...
Eligibility Criteria
Inclusion
- Ambulatory
- No significant health problems that would impair the completion of the physical activity tasks, does not carry any diagnosis of developmental delay and/or significant co-morbid medical conditions as determined by a medically qualified individual during medical history review
Exclusion
- Participation in other studies involving digital devices within 1 week and/or treatment with an investigational drug (Phases 1-4) within 30 days or 5 half-lives before the current study begins and/or during study participation.
- Participants with implanted medical devices.
- Minor participants who reach the age of majority during the study, as recognized under local law.
- Any medical or psychiatric condition that may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study.
- Participants with known allergies to components as specified by device manufacturer if applicable (eg, plastic, stainless steel and silicone).
Key Trial Info
Start Date :
August 23 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 28 2024
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT04823650
Start Date
August 23 2021
End Date
October 28 2024
Last Update
December 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Innovation Research, PfIRe, Lab
Cambridge, Massachusetts, United States, 02139